Bortezomib-cyclophosphamide-dexamethasone (VCd or CyBorD) treatment evaluations

PatientsLikeMe would like to remind you that your browser is out of date and many features of the website may not function as expected. Please update your browser for more security and a better experience.

Skip over navigation

Sep 3, 2015 (Started May 30, 2015)

Effectiveness

Major (for multiple myeloma)
Side effects

Moderate (for Overall) (peripheral neuropathy)
Adherence

Always
Burden

Somewhat hard to take

Dosage: Weekly

Jun 4, 2015 (Started May 30, 2015)

Effectiveness

Major (for multiple myeloma)
Side effects

Moderate (for Overall) (peripheral neuropathy)
Adherence

Always
Burden

A little hard to take

Dosage: Weekly

0 helpful marks

▲ Back to top